Physician profile
Gary C Berliner
NPI 1164564910
$752.56
in general payments reported to CMS, 2019-2025
15 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.64 · 2020: $147 · 2021: $70.93 · 2022: $69.06 · 2023: $214 · 2024: $60.78 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $156.90 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $132.75 | 2024-2025 | Airsupra |
| Paratek Pharmaceuticals, INC. | $87.84 | 2023-2025 | Nuzyra |
| Eisai INC. | $86.35 | 2020-2021 | |
| Lilly USA, LLC | $55.87 | 2020 | |
| Abbott Laboratories | $42.07 | 2023 | Freestyle Libre 3 |
| Medtronic, INC. | $41.66 | 2024 | Interstim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.40 | 2020 | |
| Athena Bioscience, LLC | $20.90 | 2025 | Nexiclon Xr |
| Otsuka America Pharmaceutical, INC. | $19.91 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $19.64 | 2019 | |
| Abbvie INC. | $17.26 | 2022 | |
| Novo Nordisk INC | $16.12 | 2020 | |
| Genentech USA, INC. | $16.11 | 2021 | |
| Idorsia Pharmaceuticals US INC | $15.78 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Berliner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.